Frequency Therapeutics reports phase I/II data on FX-322 for hearing restoration April 9, 2019 No Comments
Positive results announced from phase I study of LY-3056480 in sensorineural hearing loss Feb. 7, 2019 No Comments
Sound Pharmaceuticals enrolls first patient in STOP Ototoxicity phase II study of SPI-1005 Jan. 15, 2019 No Comments
Spiral Therapeutics initiates phase I trial of new hearing loss drug, LPT-99 Dec. 19, 2018 No Comments
Seliforant shown not to affect vigilance, cognitive performance during motion stimulus Dec. 14, 2018 No Comments
Sensorion signs letter of intent with Institut Pasteur for hearing loss gene therapy programs Nov. 23, 2018 No Comments
RSS